Contortrostatin, a Homodimeric Disintegrin, Actively Disrupts Focal Adhesion and Cytoskeletal Structure and Inhibits Cell Motility Through a Novel Mechanism

References

• Angers-Loustau A., Cote J.-F., Charest A., Dowbenko D., Spencer S., Lasky L. A., Tremblay M. L. Protein tyrosine phosphatase-PEST regulates Focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J. Cell Biol. 1999; 144: 1019–1031
   PubMed Web of Science ®Google Scholar
• Aznavoorian S., Stracke M. L., Parsons J., McClanahan J., Liotta L. A. Integrin alphavbeta3 mediates chemotactic and haptotactic motility in human melanoma cells through different signaling pathways. J. Biol. Chem. 1996; 271: 3247–3254
   PubMed Web of Science ®Google Scholar
• Beviglia L., Stewart G. J., Niewiarowski S. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncology Research 1995; 7: 7–20
   PubMed Web of Science ®Google Scholar
• Bhattacharya S., Fu C., Bhattacharya J., Greenberg S. Soluble ligands of the αvβ3 integrin mediate enhanced tyrosine phosphorylation of multiple proteins in adherent bovine pulmonary artery endothelial cells. J. Biol. Chem. 1995; 270: 16781–16787
   PubMed Web of Science ®Google Scholar
• Brooks P. C., Clark R. A., Cheresh D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994a; 264: 569–571
   PubMed Web of Science ®Google Scholar
• Brooks P. C., Montgomery A. M.P., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., Cheresh D. A. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994b; 79: 1157–1164
   PubMed Web of Science ®Google Scholar
• Brooks P. C., Silletti S., Von Schalscha T. L., Friedlander M., Cheresh D. A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998; 92: 391–400
   PubMed Web of Science ®Google Scholar
• Brooks P. C., Stromblad S., Sanders L. C., Von Schalscha T. L., Aimes R. T., Stetler-Stevenson W. G., Quigley J. P., Cheresh D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996; 85: 683–693
   PubMed Web of Science ®Google Scholar
• Burridge K., Fath K., Kelly T., Nuckolls G., Turner C. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. A. Rev. Cell Biol. 1988; 4: 487–525
   PubMedGoogle Scholar
• Burridge K., Turner C. E., Romer L. H. Tyrosine phosphorylation of paxillin and pp125FAKaccompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly. J. Cell Biol. 1992; 119: 893–903
   PubMed Web of Science ®Google Scholar
• Cary L. A., Han D. C., Polte T. R., Hanks S. K., Guan J.-L. Identification of p130Casas a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. 1998; 140: 211–221
   PubMed Web of Science ®Google Scholar
• Cobb B. S., Schaller M. D., Leu T. H., Parsons J. T. Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125 FAK. Mol. Cell. Biol. 1994; 14: 147–155
   PubMed Web of Science ®Google Scholar
• Friedman E., Verderame M., Lipkin M., Pollack R. Altered actin cytoskeletal patterns in two premalignant stages in human colon carcinoma development. Cancer Research 1985; 45: 3236–3242
   PubMed Web of Science ®Google Scholar
• Garton A. J., Tonks N. K. Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST. J. Biol. Chem. 1999; 274: 3811–3818
   PubMed Web of Science ®Google Scholar
• Giancotti F. G., Ruoslahti E. Integrin signaling. Science 1999; 285: 1028–1032
   PubMed Web of Science ®Google Scholar
• Gilmore A. P., Romer L. H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell 1996; 7: 1209–1224
   PubMed Web of Science ®Google Scholar
• Huang T.-F., Holt J. C., Lukasiewicz H., Niewiarowski S. Trigramin: A low molecular weight peptide inhibiting fibrinogen interaction with platelet expressed on glycoprotein IIb-IIIa complex. J. Biol. Chem. 1987; 262: 16157–16163
   PubMed Web of Science ®Google Scholar
• Kang I.-C., Lee Y.-D., Kim D.-S. A novel disin-tegrin salmosin inhibits tumor angiogenesis. Cancer Research 1999; 59: 3754–3760
   PubMed Web of Science ®Google Scholar
• Keely P., Parise L., Juliano R. Integrins and GTPases in tumour cell growth, motility and invasion. Trends Cell Biol. 1998; 8: 101–106
   PubMed Web of Science ®Google Scholar
• Klemke R. L., Leng J., Molander R., Brooks P. C., Vuori K., Cheresh D. A. CAS/Crk coupling serves as a “Molecular Switch” for induction of cell migration. J. Cell Biol. 1998; 140: 961–972
   PubMed Web of Science ®Google Scholar
• Kornberg L. J., Earp H. S., Turner C. E., Prockop C., Juliano R. L. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins. Proc. Nail. Acad. Sci. USA 1991; 88: 8392–8396
   PubMed Web of Science ®Google Scholar
• Lin E. C.K., Ratnikov B. I., Tsai P. M., Carron C. P., Myers D. M., Barbas C.F., Smith J. Identification of a region in the integrin β3 subunit that confers ligand binding specificity. J. Biol. Chem. 1997; 272: 23912–23920
   PubMed Web of Science ®Google Scholar
• Lipfert L., Haimovich B., Schaller M. D., Cobb B. S., Parsons J. T., Brugge J. S. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAKin platelets. J. Cell Biol. 1992; 119: 905–912
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz C., Calvete J. J., Marcinkiewicz M. M., Raida M., Vijay-Kumar S., Huang Z., Lobb R. R., Niewiarowski S. EC3, a novel heterodimeric disintegrin fromEchis carinatusvenom, inhibits α4 and α5 integrins in an RGD-independent manner. J. Biol. Chem. 1999a; 274: 12468–12473
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz C., Calvete J. J., Vijay-Kumar S., Marcinkiewicz M. M., Raida M., Schick P., Lobb R. R., Niewiarowski S. Structural and functional characterization of EMF10, a heterodimeric disintegrin from eristocophis macmahoni venom that selectively inhibits alpha 5 beta 1 integrin. Biochemistry 1999b; 38: 13302–13309
   PubMed Web of Science ®Google Scholar
• Markland F. S., Zhou Q. Snake venom disintegrin: an effective inhibitor of breast cancer growth and dissemination. Natural and Selected Synthetic Toxins: Biological Implications, A. T. Tu, W. Gaffield. American Chemical Society, Washington, DC 2000; 262–282, ACS Symposium Series #745
   Google Scholar
• Miyamoto S., Teramoto H., Coso O. A., Gutkind J. S., Burbelo P. D., Akiyama S. K., Yamada K. M. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 1995; 131: 791–805
   PubMed Web of Science ®Google Scholar
• Niewiarowski S., McLane M. A., Kloczewiak M., Stewart G. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Seminars in Hematology 1994; 31: 289–300
   PubMed Web of Science ®Google Scholar
• Oktay M., Wary K. K., Dans M., Birge R. B., Giancotti F. G. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the Gl phase of the cell cycle. J. Cell Biol. 1999; 145: 1461–1469
   PubMed Web of Science ®Google Scholar
• Oshikawa K., Terada S. Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom. J. Biochem. 1999; 125: 31–35
   PubMed Web of Science ®Google Scholar
• Petitclerc E., Stromblad S., Von Schalscha T. L., Mitjans F., Piulats J., Montgomery A. M., Cheresh D. A., Brooks P. C. lntegrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Research 1999; 59: 2724–2730
   PubMed Web of Science ®Google Scholar
• Pfaff M., McLane M. A., Beviglia L., Niewiarowski S., Timpl R. Comparison of disintegrins with limited variation in the RGO loop in their binding to purified integ-rins αIIbβ3, αvβ3 and α5β1 and in cell adhesion inhibition. Cell Adhesion Commun. 1994; 2: 491–501
   PubMed Web of Science ®Google Scholar
• Price J. E., Polyzos A., Zhang R. D., Daniels L. M. Tumorigenicity and Metastasis of human breast carcinoma cell Lines in nude mice. Cancer Research 1990; 50: 717–721
   PubMed Web of Science ®Google Scholar
• Repesh L. A. A Newin vitroAssay for quantitating tumor cell invasion. Invasion and Metastasis 1989; 9: 192–208
   PubMedGoogle Scholar
• Ritter M. R., Markland F. S. Differential regulation of tyrosine phosphorylation in tumor cells by contortrostatin, a homodimeric disintegrin, and monomelic disintegrins echistatin and flavoridin. Toxicon 2001; 39: 283–289
   PubMed Web of Science ®Google Scholar
• Ritter M. R., Zhou Q., Markland F. S. Contortrostatin, A snake venom disintegrin, induces αvβ3-mediated tyrosine phosphorylation of CAS and FAK in tumor cells. J. Cell. Biochem. 2000; 79: 28–37
   PubMed Web of Science ®Google Scholar
• Rodriguez-Fernandez J. L. Why do so many stimuli induce tyrosine phosphorylation of FAK?. Bioessays 1999; 21: 1069–1075
   PubMed Web of Science ®Google Scholar
• Schaller M. D., Hildebrand J. D., Shannon J. D., Fox J. W., Vines R. R., Parsons J. T. Autophosphorylation of the focal adhesion kinase, pp125FAKdirects SH2-dependent binding of pp60src. Mol. Cell. Biol. 1994; 14: 1680–1688
   PubMed Web of Science ®Google Scholar
• Schilder R. J., Hall L., Monks A., Handel L. M., Fornace A. J., Jr., Ozols R. F., Fqjo A. T., Hamilton T. C. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. International J. Cancer 1990; 45: 416–422
   PubMed Web of Science ®Google Scholar
• Schlaepfer D. D., Hanks S. K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786–791
   PubMed Web of Science ®Google Scholar
• Schlaepfer D. D., Jones K. C., Hunter T. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol. Cell. Biol. 1998; 18: 2571–2585
   PubMed Web of Science ®Google Scholar
• Senn H., Klaus W. The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. J. Mol. Biol. 1993; 232: 907–925
   PubMed Web of Science ®Google Scholar
• Sheu J.-R., Yen M.-H., Kan Y.-C., Hung W.-C., Chang P.-T., Luk H.-N. Inhibition of angiogenesisin vitroandin vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-αvβ3 integrin monoclonal antibody. Biochim. Biophys. Acta 1997; 1336: 445–454
   PubMed Web of Science ®Google Scholar
• Sieg D. J., Hauck C. R., Schlaepfer D. D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 1999; 112: 2677–2691
   PubMed Web of Science ®Google Scholar
• Tam S. H., Sassoli P. M., Jordan R. E., Nakada M. T. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of GPIIb/IIIa and αvβ3 integrins. Circulation 1998; 98: 1085–1091
   PubMed Web of Science ®Google Scholar
• Trikha M., de Clerck Y. A., Markland F. S. Contortrostatin, a snake venom disintegrin, inhibits β1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Research 1994a; 54: 4993–4998
   PubMed Web of Science ®Google Scholar
• Trikha M., Rote W., Manley P., Lucchesi B. R., Mark-Land F. S. Purification and characterization of platelet aggregation inhibitors from snake venoms. Thrombosis Research 1994b; 73: 39–52
   PubMed Web of Science ®Google Scholar
• Vuori K., Hirai H., Aizawa S., Ruoslahti E. Induction of p130cassignaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol. Cell. Biol. 1996; 16: 2606–2613
   PubMed Web of Science ®Google Scholar
• Wong N. C., Mueller B. M., Barbas C. F., Ruminski P., Quaranta V., Lin E. C., Smith J. W. Alpha v integrins mediate adhesion and migration of breast carcinoma cell lines. Clinical Exp. Metastasis 1998; 16: 50–61
   PubMed Web of Science ®Google Scholar
• Yamakita Y., Totsukawa G., Yamashiro S., Fry D., Zhang X., Hanks S. K., Matsumura F. Dissociation of FAK/p130(CAS)/c-Src complex during mitosis: role of mitosis-specific serine phosphorylation of FAK. J. Cell Biol. 1999; 144: 315–324
   PubMed Web of Science ®Google Scholar
• Yeh C. H., Peng H.-C., Huang T.-F. Accutin, a new disintegrin, inhibits angiogenesisin vitroandin vivoby acting as integrin αvβ3 antagonist and inducing apoptosis. Blood 1998; 92: 3268–3276
   PubMed Web of Science ®Google Scholar
• Zhou Q., Nakada M., Arnold C., Shieh K. Y., Markland F. S. Contortrostatin, a dimeric disintegrin fromAgkistrodon contortrix contortrixinhibits angiogenesis. Angiogenesis 1999; 3: 259–269
   PubMedGoogle Scholar
• Zhou Q., Hu P., Ritter M. R., Swenson S. D., Argounova S., Epstein A. L., Markland F. S. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom. Archs Biochem. Biophys. 2000a; 375: 278–288
   PubMed Web of Science ®Google Scholar
• Zhou Q., Nakada M. T., Brooks P.C, Swenson S. D., Ritter M. R., Argounova S., Arnold C., Markland F. S. Contortrostatin, a homodimeric disintegrin, binds to integrin αvβ5. Biochem. Biophys. Res. Commun. 2000b; 267: 350–355
   PubMed Web of Science ®Google Scholar
• Zhou Q., Sherwin R. P., Parrish C., Richters V., Groshen S. G., Tsao-Wei D., Markland F. S. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression. Breast Cancer Res. Treat. 2000c; 61(3)249–260
   PubMed Web of Science ®Google Scholar